EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Device-Detected Atrial Fibrillation: Why Time-Based Thresholds Are No Longer Fit for Purpose

Ahmed El-Medany iD

Journal of Clinical Medicine · 14.04.2026 · 15 (8) · 2961

DOI: 10.3390/jcm15082961 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.04.2026. Verfasst von Ahmed El-Medany. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Institute for Health and Care Research, Cardiology Research Department at North Bristol NHS Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in implantable and wearable cardiac monitoring technologies have led to widespread detection of brief, often asymptomatic atrial high-rate episodes, frequently labelled as device-detected atrial fibrillation (AF). While detection has increased substantially, the clinical interpretation of these findings remains uncertain. Observational studies demonstrate associations between AF burden and stroke risk but reveal marked inter-individual heterogeneity and no consistent temporal threshold below which risk is eliminated. Recent randomised controlled trials show that anticoagulation guided solely by arrhythmia duration confers limited net clinical benefit, with modest reductions in ischaemic stroke offset by increased bleeding. These findings challenge the biological and clinical validity of rigid time-based thresholds for intervention. Increasing evidence suggests that AF may act primarily as a marker of underlying atrial disease rather than the sole mechanistic cause of thromboembolism. This article provides an evidence-informed perspective on the interpretation of device-detected AF in contemporary clinical practice and argues for a shift away from duration-based triggers toward a longitudinal, risk-adapted approach that integrates AF trajectory, atrial substrate, and clinical context. Emerging tools such as artificial intelligence-enhanced electrocardiography may help identify occult atrial pathology but must augment rather than replace clinical judgement. Proportionate, individualised care should supersede reflexive treatment strategies in the management of device-detected AF.

Schlagwörter

Stichwörter der Autor:innen

anticoagulationartificial intelligenceatrial cardiomyopathyatrial fibrillationatrial high-rate episodescardiac implantable electronic devicescardiac monitoringstroke preventionwearable technology

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.
  • Chelsea and Westminster NHS Foundation Trust, London SW10 9NH, UK.
  • Imperial College Healthcare NHS Trust, London W2 1NY, UK.
  • North Bristol NHS Trust, Bristol BS10 5NB, UK.
  • University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.

ORCID-Profile: Ahmed El-Medany

Förderung

  • British Heart Foundation
  • National Institute for Health and Care Research
  • Cardiology Research Department at North Bristol NHS Trust

Zitieren

APA

El-Medany, A. (2026). Device-Detected Atrial Fibrillation: Why Time-Based Thresholds Are No Longer Fit for Purpose. Journal of Clinical Medicine, 15(8), 2961. https://doi.org/10.3390/jcm15082961

Vancouver

El-Medany A. Device-Detected Atrial Fibrillation: Why Time-Based Thresholds Are No Longer Fit for Purpose. Journal of Clinical Medicine. 2026;15(8):2961. doi:10.3390/jcm15082961

BibTeX
@article{ElMedany2026,
  author = {El-Medany, Ahmed},
  title = {Device-Detected Atrial Fibrillation: Why Time-Based Thresholds Are No Longer Fit for Purpose},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {2961},
  doi = {10.3390/jcm15082961}
}
Kostenlos starten →